Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease.
NCT03350165 is registered in ClinicalTrials.gov with Kowa Company, Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease.
- Lead sponsor
- Kowa Company, Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 27, 2017
- Completion date
- June 30, 2020
- Enrollment
- 118 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.